Therapeutic Respiratory Devices Market Report 2023-2033
/PRNewswire/ -- Forecasts by Product (Inhalers (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), Ventilators (Adult Ventilators, Neonatal...
Source: prnewswire.com
Page 18 - Cipla Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cipla Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cipla Inc Today - Breaking & Trending Today
Rheumatic Heart Disease Management Market Will Hit USD 1.66 Billion By 2031, Because of the Rising Prevalence of the Disease | Growth Plus Reports |
The latest report from Growth Plus Reports analyzes the product, potential applications, demand, major manufacturers, and SWOT analysis of the global
Source: medgadget.com
Non-Opioid Pain Treatment Market to Hit US$ 79.46 Billion By 2031, Due to the Rising Prevalence of Chronic Diseases, says Growth Plus Reports |
According to a recent Growth Plus Reports study, the global non-opioid pain treatment market is estimated to hit US$ 79.46 billion by 2031, with a revenue
Source: medgadget.com
Global Generic Pharmaceuticals Market Report 2023: Sector
Dublin, March 20, 2023 (GLOBE NEWSWIRE) -- The "Generic Pharmaceuticals Market Size, Share & Trends Analysis Report By Type (Simple Generics,...
Source: globenewswire.com
Geriatric Population to sweep the Glaucoma Treatment Market, reaching US$ 8 Billion at a CAGR of 3.2
The global Glaucoma Treatment Market holds a valuation of US$ 5.7 Billion by the end of the year 2022. During the forecast period of 2023 to 2033, the market is expected to grow at a CAGR of 3.2%, with a market value of around US$ 8.0 billion in 2033.The elderly population is more into getting infected by glaucoma t...
Source: pharmiweb.com